| Dec'19 | Dec'18 | Dec'17 | Dec'16 | |||
|---|---|---|---|---|---|---|
Cash Flows From Operating Activities | ||||||
Net loss | ||||||
-21,156 | -17,253 | -5,129 | -3,533 | |||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation and amortization | ||||||
15 | 19 | 25 | 12 | |||
Stock-based compensation | ||||||
2,511 | 1,615 | 412 | 2 | |||
Changes in operating assets and liabilities: | ||||||
Prepaid expenses and other current assets | ||||||
63 | 95 | 34 | -310 | |||
Accounts payable | ||||||
31 | 1,263 | -55 | 55 | |||
Accrued compensation | ||||||
4 | 912 | - | - | |||
Accrued expenses and other current liabilities | ||||||
-266 | 503 | 51 | -51 | |||
Security deposit | ||||||
0 | -117 | 0 | - | |||
Deferred rent | ||||||
3 | 41 | 0 | - | |||
Net Cash Used In Operating Activities | ||||||
-18,919 | -13,111 | -4,731 | -3,203 | |||
Cash Flows From Investing Activities | ||||||
Purchases of property and equipment | ||||||
166 | 27 | 10 | 43 | |||
Net Cash Used In Investing Activities | ||||||
-166 | -27 | -10 | -43 | |||
Cash Flows From Financing Activities | ||||||
Proceeds from sale of warrant | ||||||
- | - | 431 | 0 | |||
Proceeds from advances related to Series B Convertible Preferred Stock | ||||||
- | - | 6,409 | - | |||
Payment of private placement issuance costs | ||||||
- | - | 41 | - | |||
Proceeds from sale of common stock in initial public offering | ||||||
0 | 25,089 | - | - | |||
Payment of initial public offering issuance costs | ||||||
0 | 345 | 195 | 0 | |||
Proceeds from sale of common stock in follow-on public offering | ||||||
0 | 3,084 | 0 | - | |||
Payment of follow-on public offering issuance costs | ||||||
0 | 266 | 0 | - | |||
Proceeds from sale of common stock in public offering | ||||||
13,214 | 0 | 0 | - | |||
Payment of public offering issuance costs | ||||||
256 | 0 | - | - | |||
Proceeds from exercise of stock options | ||||||
551 | 56 | 0 | - | |||
Net Cash Provided By Financing Activities | ||||||
13,510 | 27,617 | 6,603 | 4,141 | |||
Net Decrease in Cash | ||||||
-5,575 | 14,478 | - | - | |||
Supplemental Disclosure of Cash Flow Information: | ||||||
Net (Decrease) Increase in Cash and Cash Equivalents | ||||||
- | - | 1,862 | 894 | |||
Supplemental Disclosure of Non-Cash Investing and Financing Activities | ||||||
Accrued purchases of leasehold improvements | ||||||
42 | 0 | - | - | |||
Exercise of warrants on a cashless basis | ||||||
0 | 0 | 0 | - | |||
Exercise of warrants on a cashless basis | ||||||
0 | 0 | - | - | |||
Accrual of intitial public offering costs | ||||||
- | - | - | 0 | |||
Conversion of convertible preferred stock into common stock | ||||||
0 | 0 | 0 | 0 | |||
Accrual of deferred offering costs | ||||||
- | - | 133 | - | |||
Reversal of previously accrued initial public offering issuance costs | ||||||
0 | -133 | 0 | - | |||
Reclassification to additional paid-in capital for initial public offering issuance costs that were previously paid | ||||||
0 | -195 | 0 | - | |||